Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash at East South and South McCall Avenues


2 Vehicles Collide in Fatal Selma Accident

Fatal Accident 3

Selma, CA (October 2, 2019) – One person was killed in a crash in Selma. The fatal accident occurred on the morning of October 2 at East South and South McCall avenues. 

The driver of a Nissan was heading west on East South when they turned onto McCall. The driver of a truck slammed into the Nissan. The passenger in the Nissan died at the accident scene. The driver of the Nissan was injured and taken to a local hospital. CHP says the driver of the truck complained of pain.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Selma

#93662


May 27, 2020

Pedestrian Killed in Crash at 10th Street West and Avenue N

Victim Hit by Car in Fatal Palmdale Accident...


April 24, 2020

3 Injured in Crash on 110 Freeway Near Slauson Avenue

5 Vehicles Involved in Los Angeles Accident...


November 25, 2019

Mireya Rivera Avila Killed in Crash on Colima Road

Driver Faces DUI Charge in Fatal Whittier Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.